Sigal L, Williams S, Soltys B, Gupta R
Cell Mol Neurobiol. 2002; 21(5):477-95.
PMID: 11860186
PMC: 11533818.
DOI: 10.1023/a:1013815322485.
Giambartolomei G, Dennis V, Philipp M
Infect Immun. 1998; 66(6):2691-7.
PMID: 9596735
PMC: 108257.
DOI: 10.1128/IAI.66.6.2691-2697.1998.
Sigal L, Williams S
Infect Immun. 1997; 65(5):1722-8.
PMID: 9125553
PMC: 175205.
DOI: 10.1128/iai.65.5.1722-1728.1997.
Pachner A, Ricalton N, Delaney E
J Clin Microbiol. 1993; 31(2):208-14.
PMID: 8432804
PMC: 262737.
DOI: 10.1128/jcm.31.2.208-214.1993.
Ma Y, Weis J
Infect Immun. 1993; 61(9):3843-53.
PMID: 8359905
PMC: 281085.
DOI: 10.1128/iai.61.9.3843-3853.1993.
Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.
Tai K, Ma Y, Weis J
Infect Immun. 1994; 62(2):520-8.
PMID: 8300210
PMC: 186137.
DOI: 10.1128/iai.62.2.520-528.1994.
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues.
Yang L, Weis J, Eichwald E, Kolbert C, Persing D, Weis J
Infect Immun. 1994; 62(2):492-500.
PMID: 8300208
PMC: 186134.
DOI: 10.1128/iai.62.2.492-500.1994.
Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line.
Fikrig E, Berland R, Chen M, Williams S, Sigal L, Flavell R
Proc Natl Acad Sci U S A. 1993; 90(1):183-7.
PMID: 7678336
PMC: 45624.
DOI: 10.1073/pnas.90.1.183.
Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.
Seiler K, Vavrin Z, Eichwald E, Hibbs Jr J, Weis J
Infect Immun. 1995; 63(10):3886-95.
PMID: 7558296
PMC: 173547.
DOI: 10.1128/iai.63.10.3886-3895.1995.
Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway.
Ma Y, Seiler K, Tai K, Yang L, Woods M, Weis J
Infect Immun. 1994; 62(9):3663-71.
PMID: 7520417
PMC: 303016.
DOI: 10.1128/iai.62.9.3663-3671.1994.
Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals.
Simpson W, BURGDORFER W, Schrumpf M, Karstens R, Schwan T
J Clin Microbiol. 1991; 29(2):236-43.
PMID: 2007630
PMC: 269746.
DOI: 10.1128/jcm.29.2.236-243.1991.
Intracellular localization of Borrelia burgdorferi within human endothelial cells.
Ma Y, Sturrock A, Weis J
Infect Immun. 1991; 59(2):671-8.
PMID: 1987083
PMC: 257809.
DOI: 10.1128/iai.59.2.671-678.1991.
Molecular and immunological analysis of a polymorphic periplasmic protein of Borrelia burgdorferi.
Simpson W, Schrumpf M, Hayes S, Schwan T
J Clin Microbiol. 1991; 29(9):1940-8.
PMID: 1774319
PMC: 270239.
DOI: 10.1128/jcm.29.9.1940-1948.1991.
Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi.
Schoenfeld R, Araneo B, Ma Y, Yang L, Weis J
Infect Immun. 1992; 60(2):455-64.
PMID: 1730476
PMC: 257649.
DOI: 10.1128/iai.60.2.455-464.1992.
Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice.
Yang L, Ma Y, Schoenfeld R, Griffiths M, Eichwald E, Araneo B
Infect Immun. 1992; 60(8):3033-41.
PMID: 1639470
PMC: 257278.
DOI: 10.1128/iai.60.8.3033-3041.1992.
Current recommendations for the treatment of Lyme disease.
Sigal L
Drugs. 1992; 43(5):683-99.
PMID: 1379147
DOI: 10.2165/00003495-199243050-00005.
